N-NITROSAMINE IMPURITIES IN PHARMACEUTICALS: FORMATION PATHWAYS, TOXICOLOGICAL CONCERNS, REGULATORY APPROACHES AND RISK MITIGATION STRATEGIES
Background: N-nitrosamine impurities represent an important pharmaceutical quality and patient safety concern because several members of this chemical class exhibit mutagenic and carcinogenic potential. Objective: To synthesize scientific and regulatory evidence concerning their formation, toxicological assessment, an...